Skip to main content
Top
Published in: Supportive Care in Cancer 5/2019

01-05-2019 | Original Article

Developing innovative models of care for cancer survivors: use of implementation science to guide evaluation of appropriateness and feasibility

Authors: Erin E. Hahn, Corrine E. Munoz-Plaza, Joanne E. Schottinger, Farah M. Brasfield, Michael K. Gould, Carla Parry

Published in: Supportive Care in Cancer | Issue 5/2019

Login to get access

Abstract

Purpose

Limited understanding of factors affecting uptake and outcomes of different cancer survivorship care models hampers implementation of best practices. We conducted a formative evaluation of stakeholder-perceived acceptability and feasibility of an embedded primary care provider (PCP) survivorship care model.

Methods

We identified clinical, operational, and patient stakeholders within Kaiser Permanente Southern California and conducted semi-structured interviews. Analyses were guided by the Consolidated Framework for Implementation Research (CFIR), an integrated framework from the field of implementation science. Deductive thematic categories were derived a priori from CFIR domains; thematic sub-categories were developed inductively.

Results

We interviewed 12 stakeholders; multiple themes were identified. Acceptability: oncologists and operational leaders perceived that the model was an acceptable solution to issues of capacity and efficiency with the potential to improve quality; however, several oncologists perceived negative consequences including “[loss of] the joy of medicine.” Patients were less enthusiastic, fearing the introduction of “[someone] who doesn’t know me.” Feasibility: confidence was high that this model can succeed, although there was concern about finding the right PCP and investment in training and staff support. Culture/climate: numerous system-level facilitators were identified, including encouragement of innovation and familiarity with developing new models.

Conclusions

Formative evaluation is a critical pre-implementation process. Acceptability and feasibility for this model were high among oncologists and operational leaders but patients were ambivalent. Keys to successful implementation include training and support of engaged PCPs and a patient transition plan introduced early in the care trajectory.
Literature
1.
go back to reference American Cancer Society (2016) Cancer Treatment & Survivorship Facts & Figures 2016–2017. American Cancer Society, Atlanta American Cancer Society (2016) Cancer Treatment & Survivorship Facts & Figures 2016–2017. American Cancer Society, Atlanta
2.
go back to reference Giese-Davis J, Hermanson K, Koopman C, Weibel D, Spiegel D (2000) Quality of couples’ relationship and adjustment to metastatic breast cancer. J Fam Psychol 14(2):251–266CrossRefPubMed Giese-Davis J, Hermanson K, Koopman C, Weibel D, Spiegel D (2000) Quality of couples’ relationship and adjustment to metastatic breast cancer. J Fam Psychol 14(2):251–266CrossRefPubMed
3.
go back to reference Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC
4.
go back to reference Damaskos P, Parry C (2015) Cancer survivorship. Handbook of oncology social work. Oxford University Press, Oxford Damaskos P, Parry C (2015) Cancer survivorship. Handbook of oncology social work. Oxford University Press, Oxford
9.
go back to reference Adler N, Page A (2008) Cancer care for the whole patient: meeting psychosocial health needs. National Academies Press, Washington D.C Adler N, Page A (2008) Cancer care for the whole patient: meeting psychosocial health needs. National Academies Press, Washington D.C
15.
go back to reference Viswanathan M, Halpern M, et al (2014) Models of Cancer Survivorship Care. In: AHRQ Comparative Effectiveness Technical Briefs. Agency for Healthcare Research and Quality, Rockville, MD, Report No: 14-EHC011-EF Viswanathan M, Halpern M, et al (2014) Models of Cancer Survivorship Care. In: AHRQ Comparative Effectiveness Technical Briefs. Agency for Healthcare Research and Quality, Rockville, MD, Report No: 14-EHC011-EF
21.
go back to reference Levit L, Balogh E (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. National Academies Press, Washington DCCrossRef Levit L, Balogh E (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. National Academies Press, Washington DCCrossRef
23.
go back to reference Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, Aubin M, Chasen M, Earle CC, Friedman AJ, Green E, Jones GW, Jones JM, Parkinson M, Payeur N, Sabiston CM, Sinclair S (2012) Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence. J Cancer Surviv 6(4):359–371. https://doi.org/10.1007/s11764-012-0232-z CrossRefPubMed Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, Aubin M, Chasen M, Earle CC, Friedman AJ, Green E, Jones GW, Jones JM, Parkinson M, Payeur N, Sabiston CM, Sinclair S (2012) Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence. J Cancer Surviv 6(4):359–371. https://​doi.​org/​10.​1007/​s11764-012-0232-z CrossRefPubMed
28.
go back to reference Rimer B, Keintz MK, Glassman B (1985) Cancer patient education: reality and potential. Prev Med 14(6):801–818CrossRefPubMed Rimer B, Keintz MK, Glassman B (1985) Cancer patient education: reality and potential. Prev Med 14(6):801–818CrossRefPubMed
30.
go back to reference Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO (1995) Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 52(2):100–113CrossRefPubMed Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO (1995) Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 52(2):100–113CrossRefPubMed
33.
Metadata
Title
Developing innovative models of care for cancer survivors: use of implementation science to guide evaluation of appropriateness and feasibility
Authors
Erin E. Hahn
Corrine E. Munoz-Plaza
Joanne E. Schottinger
Farah M. Brasfield
Michael K. Gould
Carla Parry
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4425-5

Other articles of this Issue 5/2019

Supportive Care in Cancer 5/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine